Thalocan Research Innovations and AGAPE Strategic Solutions of Maryland, LLC align on the significance of including patient perspectives and the social determinant of health in clinical research that includes the input of all relevant populations. Building trust in the engagement process and utilizing patient-centered tools to capture the accuracy of clinician and patient-reported outcomes help…
August is observed as hair loss awareness month, and we here at Thalocan Research Innovations are proud to join organizations like the National Alopecia Areata Foundation in raising awareness and drawing attention to this significant challenge that can impact a person’s health, confidence and overall well-being. Recently, we partnered with Arash Mostaghimi, MD, MPA, MPH…
Old school paper record keeping is time-consuming with a higher potential for missteps. Avoiding this is just ONE of the many reasons we designed LAMA. A patent-pending, BYOD cloud-based solution, Thalocan’s Lesion Area Mapping Assistant (LAMA) is built on a single concept: improve lesion assessment during dermatologic clinical trials with a streamlined, comprehensive and structured…
Eric Zudak, CEO of Thalocan Research Innovations, discusses Thalocan’s role in helping to address unmet needs in the immunodermatology area. With many, if not most inflammatory skin diseases being more common in Skin of Color than in lighter pigmented skin – Thalocan is proud to provide cutting edge technology, training and tools for more accurate scientific…
